Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Metadata
Title
Measuring the impact of medicines information services on patient care: methodological considerations
Authors
Anne Spinewine
Bryony Dean
Publication date
01-10-2002
Publisher
Kluwer Academic Publishers
Published in
International Journal of Clinical Pharmacy / Issue 5/2002
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1023/A:1020575031753

Other articles of this Issue 5/2002

International Journal of Clinical Pharmacy 5/2002 Go to the issue

OriginalPaper

Using the Internet to develop an international learning community of pharmacists

OriginalPaper

The identification of barriers preventing the successful implementation of a surgical prophylaxis protocol

OriginalPaper

The lay user perspective on the quality of pharmaceuticals, drug therapy and pharmacy services – results of focus group discussions

OriginalPaper

Erratum

OriginalPaper

Desire for information about drugs: relationships with patients' characteristics and adverse effects

OriginalPaper

Survey of drug use practices and antibiotic prescribing pattern at a general hospital in Nigeria

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits